Cellular Biomedicine Group (CBMG) Swings to Q3 Loss
Tweet
Share
E-mailGet Alerts CBMG Hot Sheet
Join SI Premium – FREE
Cellular Biomedicine Group (NASDAQ: CBMG) reported Q3 EPS of ($0.31), versus $0.09 reported last year.
For earnings history and earnings-related data on Cellular Biomedicine Group (CBMG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
- Lamar Advertising acquires AdSource Outdoor in UPREIT deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
